Methods for treatment of non-alcoholic fatty liver diseases (nafld) using advanced microbiome therapeutics

Morten Otto Alexander Sommer (Inventor), Ruben Vazquez Uribe (Inventor), Mareike Bongers (Inventor), Hani El-Nezamy (Inventor), Marjukka Kolehmainen (Inventor), Valeria Iannone (Inventor), Johnson Lok (Inventor), Carlos Gomez Gallego (Inventor)

Research output: Patent

27 Downloads (Pure)

Abstract

The present invention relates to a composition comprising a genetically engineered non-pathogenic microorganism expressing one or more polypeptide comprising polypeptide hormones. The composition is preferably for use in the treatment of non-alcoholic fat liver disease (NAFLD).

Original languageEnglish
IPCC07K 14/ 65 A I
Patent numberWO2023208816
Filing date25/04/2022
Country/TerritoryInternational Bureau of the World Intellectual Property Organization (WIPO)
Priority date25/04/2022
Priority numberEP20220169704
Publication statusPublished - 2 Nov 2023

Fingerprint

Dive into the research topics of 'Methods for treatment of non-alcoholic fatty liver diseases (nafld) using advanced microbiome therapeutics'. Together they form a unique fingerprint.

Cite this